These findings suggest that CBD, through the Nrf2 pathway, has the potential to modulate cellular quiescence in the tumor context, in agreement with the results of our study in the U87MG glioblastoma cell line [6]. The gene discussed is NFE2L2; the disease is glioblastoma.